Drug company AstraZeneca has announced it will make a “wide range of compounds” available for free to UK medical researchers next year.
The announcement follows a deal between the company and the Medical Research Council.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.